- Patent Title: Small molecule myristate inhibitors of Bcr-abl and methods of use
-
Application No.: US14540919Application Date: 2014-11-13
-
Publication No.: US09670214B2Publication Date: 2017-06-06
- Inventor: Nathanael S. Gray , Jianming Zhang , Barun Okram , Xianming Deng
- Applicant: Nathanael S. Gray , Jianming Zhang , Barun Okram , Xianming Deng
- Applicant Address: US MA Boston US CA La Jolla
- Assignee: DANA-FARBER CANCER INSTITUTE, INC.,THE SCRIPPS RESEARCH INSTITUTE
- Current Assignee: DANA-FARBER CANCER INSTITUTE, INC.,THE SCRIPPS RESEARCH INSTITUTE
- Current Assignee Address: US MA Boston US CA La Jolla
- Agency: Brinks Gilson & Lione
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; C07D471/04 ; C07D239/42 ; C07D239/94 ; C07D403/04 ; C07D403/06 ; C07D403/12 ; C07D495/04 ; C07D417/04 ; C07D473/34 ; A61K31/517 ; A61K31/52 ; A61K31/5377 ; A61K31/7076 ; A61K45/06 ; C07H19/16
Abstract:
The present invention provides novel heteroaryl compounds of formula (I) having a pyrimidine-containing core that is linked to a 4-trifluoromethoxyphenyl group via an amine linker. Such compounds are useful for the treatment of cancers.
Public/Granted literature
- US20150094275A1 SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE Public/Granted day:2015-04-02
Information query
